Controlled trial of D-penicillamine with low dosis in the treatment of chronic liver diseases
- PMID: 6997130
- DOI: 10.1007/BF02774310
Controlled trial of D-penicillamine with low dosis in the treatment of chronic liver diseases
Abstract
Controlled trial of D-penicillamine was carried out with low dosis in 10 patients with chronic persistent hepatitis, 11 patients with chronic aggressive hepatitis and 7 patients with liver cirrhosis. After 6 weeks and 6 months treatment mean values of transaminases improved in patients with chronic persistent hepatitis. The mean serum transaminases levels of the patients with chronic aggressive hepatitis were statistically decreased after 6 weeks treatment but not significantly lower after 6 months treatment than on entry. D-penicillamine is not effective for the treatment of patients with liver cirrhosis. Eight of 36 patients treated were withdrawn from the trial because of adverse drug toxicity side effects.
Similar articles
-
[The treatment of chronic aggressive hepatitis with D-penicillamine].Dtsch Med Wochenschr. 1971 Jan 22;96(4):139-45 passim. doi: 10.1055/s-0028-1108216. Dtsch Med Wochenschr. 1971. PMID: 5539526 German. No abstract available.
-
[Treatment of chronic infantile hepatitis with D-penicillamine (author's transl)].Klin Padiatr. 1977 May;189(3):211-9. Klin Padiatr. 1977. PMID: 559874 German.
-
A prospective trial of D-penicillamine in primary biliary cirrhosis.N Engl J Med. 1982 Feb 11;306(6):319-26. doi: 10.1056/NEJM198202113060602. N Engl J Med. 1982. PMID: 7033789 Clinical Trial.
-
Treatment of chronic hepatitis.Prog Liver Dis. 1972;4:419-32. Prog Liver Dis. 1972. PMID: 4569006 Review. No abstract available.
-
[Anabolic steroids and liver diseases].Wien Med Wochenschr. 1967 Mar 25;117(12):293-9. Wien Med Wochenschr. 1967. PMID: 4871957 Review. German. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical